Going beyond the control of quorum-sensing to combat biofilm infections

Antibiotics

Volumn 5, Issue 1, 2016, Pages

  Abraham, Wolf Rainer ^a  

^a HELMHOLTZ CENTRE FOR INFECTION RESEARCH   (Germany)

Author keywords

Biofilm dispersal; Biofilm infection; Quorum sensing

Indexed keywords

ACYL CARRIER PROTEIN; CIPROFLOXACIN; EXOPOLYSACCHARIDE; N ACYLHOMOSERINE LACTONE; NITRIC OXIDE; TOBRAMYCIN; VIRULENCE FACTOR;

BIOCOMPATIBILITY; BIOFILM INFECTION; CELL COMMUNICATION; ESCHERICHIA COLI; IMMUNE SYSTEM; INFECTION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIAL COMMUNITY; NEISSERIA GONORRHOEAE; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS PUTIDA; QUORUM SENSING; REVIEW; SALMONELLA ENTERICA SEROVAR TYPHIMURIUM; SERRATIA LIQUEFACIENS; STAPHYLOCOCCUS; STREPTOCOCCUS MUTANS; TYPE III SECRETION SYSTEM;

EID: 85013653474     PISSN: None     EISSN: 20796382     Source Type: Journal    
DOI: 10.3390/antibiotics5010003     Document Type: Review

References (109)

1. Costerton, J. W.; Cheng, K. J.; Geesey, G. G.; Ladd, T. I.; Nickel, J. C.; Dasgupta, M.; Marrie, T. J. Bacterial biofilms in nature and disease. Annu. Rev. Microbiol. 1987, 41, 435-464. [CrossRef] [PubMed].
2. Singh, P. K.; Schaefer, A. L.; Parsek, M. R.; Moninger, T. O.; Welsh, M. J.; Greenberg, E. P. Quorum-sensing signals indicate that cystic fibrosis lungs are infected with bacterial biofilms. Nature 2000, 407, 762-764. [CrossRef] [PubMed].
3. Wenzel, R. P. Health care-associated infections: Major issues in the early years of the 21st century. Clin. Infect. Dis. 2007, 45 (Suppl. 1), S85-S88. [CrossRef] [PubMed].
4. Olsen, I. Biofilm-specific antibiotic tolerance and resistance. Eur. J. Clin. Microbiol. Infect. Dis. 2015, 34, 877-886. [CrossRef] [PubMed].
5. Jolivet-Gougeon, A.; Bonnaure-Mallet, M. Biofilms as a mechanism of bacterial resistance. Drug Discov. Today Technol. 2014, 11, 49-56. [CrossRef] [PubMed].
6. Cantón, R.; Morosini, M. I. Emergence and spread of antibiotic resistance following exposure to antibiotics. FEMS Microbiol. Rev. 2011, 35, 977-991. [CrossRef] [PubMed].
7. Mah, T.-F.; Pitts, B.; Pellock, B.; Walker, G. C.; Stewart, P. S.; O'Toole, G. A. A genetic basis for Pseudomonas aeruginosa biofilm antibiotic resistance. Nature 2003, 426, 306-310. [CrossRef] [PubMed].
8. Sun, J.; Deng, Z.; Yan, A. Bacterial multidrug efflux pumps: Mechanisms, physiology and pharmacological exploitations. Biochem. Biophys. Res. Commun. 2014, 453, 254-267. [CrossRef] [PubMed].
9. Waters, C. M.; Bassler, B. L. Quorum sensing: Cell-to-cell communication in bacteria. Annu. Rev. Cell Dev. Biol. 2005, 21, 319-346. [CrossRef] [PubMed].
10. Wang, Y.; Ma, S. Small molecules modulating AHL-based quorum sensing to attenuate bacteria virulence and biofilms as promising antimicrobial drugs. Curr. Med. Chem. 2014, 21, 296-311. [CrossRef] [PubMed].
11. Pereira, C. S.; Thompson, J. A.; Xavier, K. B. AI-2-mediated signalling in bacteria. FEMS Microbiol. Rev. 2013, 37, 156-181. [CrossRef] [PubMed].
12. Loh, J.; Carlson, R. W.; York, W. S.; Stacey, G. Bradyoxetin, a unique chemical signal involved in symbiotic gene regulation. Proc. Natl. Acad. Sci. USA 2002, 99, 14446-14451. [CrossRef] [PubMed].
13. Albuquerque, P.; Casadevall, A. Quorum sensing in fungi-A review. Med. Mycol. 2012, 50, 337-345. [CrossRef] [PubMed].
14. Deng, Y.; Wu, J.; Tao, F.; Zhang, L.-H. Listening to a new language: DSF-based quorum sensing in Gram-negative bacteria. Chem. Rev. 2011, 111, 160-173. [CrossRef] [PubMed].
15. Monnet, V.; Juillard, V.; Gardan, R. Peptide conversations in Gram-positive bacteria. Crit. Rev. Microbiol. 2014, 8. [CrossRef] [PubMed].
16. Novick, R. P.; Geisinger, E. Quorum sensing in staphylococci. Annu. Rev. Genet. 2008, 42, 541-564. [CrossRef] [PubMed].
17. Pichlmaier, M.; Marwitz, V.; Kühn, C.; Niehaus, M.; Klein, G.; Bara, C.; Haverich, A.; Abraham, W.-R. High prevalence of asymptomatic bacterial colonization of rhythm management devices. Europace 2008, 10, 1067-1072. [CrossRef] [PubMed].
18. Scutera, S.; Zucca, M.; Savoia, D. Novel approaches for the design and discovery of quorum-sensing inhibitors. Expert Opin. Drug Discov. 2014, 9, 353-366. [CrossRef] [PubMed].
19. Jimenez, P. N.; Koch, G.; Thompson, J. A.; Xavier, K. B.; Cool, R. H.; Quax, W. J. The multiple signaling systems regulating virulence in Pseudomonas aeruginosa. Microbiol. Mol. Biol. Rev. 2012, 76, 46-65. [CrossRef] [PubMed].
20. Hirakawa, H.; Tomita, H. Interference of bacterial cell-to-cell communication: A new concept of antimicrobial chemotherapy breaks antibiotic resistance. Front. Microbiol. 2013, 4. [CrossRef] [PubMed].
21. Jiang, T.; Li, M. Quorum sensing inhibitors: A patent review. Expert Opin. Ther. Pat. 2013, 23, 867-894. [CrossRef] [PubMed].
22. De Nys, R.; Wright, A. D.; König, G. M.; Sticher, O. New halogenated furanones from the marine red alga Delisea pulchra (cf. fimbriata). Tetrahedron 1993, 49, 11213-11220. [CrossRef].
23. Estrela, A. B.; Heck, M. G.; Abraham, W.-R. Novel approaches to control biofilm infections. Curr. Med. Chem. 2009, 16, 1512-1530. [CrossRef] [PubMed].
24. Zhou, L.; Zheng, H.; Tang, Y.; Yu, W.; Gong, Q. Eugenol inhibits quorum sensing at sub-inhibitory concentrations. Biotechnol. Lett. 2013, 35, 631-637. [CrossRef] [PubMed].
25. Rudrappa, T.; Bais, H. P. Curcumin, a known phenolic from Curcuma longa, attenuates the virulence of Pseudomonas aeruginosa PAO1 in whole plant and animal pathogenicity models. J. Agric. Food Chem. 2008, 56, 1955-1962. [CrossRef] [PubMed].
26. Jakobsen, T. H.; van Gennip, M.; Phipps, R. K.; Shanmugham, M. S.; Christensen, L. D.; Alhede, M.; Skindersoe, M. E.; Rasmussen, T. B.; Friedrich, K.; Uthe, F.; et al. Ajoene, a sulfur-rich molecule from garlic, inhibits genes controlled by quorum sensing. Antimicrob. Agents Chemother. 2012, 56, 2314-2325. [CrossRef] [PubMed].
27. Gray, B.; Hall, P.; Gresham, H. Targeting agr-and agr-Like quorum sensing systems for development of common therapeutics to treat multiple gram-positive bacterial infections. Sensors 2013, 13, 5130-5166. [CrossRef] [PubMed].
28. Balaban, N.; Cirioni, O.; Giacometti, A.; Ghiselli, R.; Braunstein, J. B.; Silvestri, C.; Mocchegiani, F.; Saba, V.; Scalise, G. Treatment of Staphylococcus aureus biofilm infection by the quorum-sensing inhibitor RIP. Antimicrob. Agents Chemother. 2007, 51, 2226-2229. [CrossRef] [PubMed].
29. Cirioni, O.; Mocchegiani, F.; Cacciatore, I.; Vecchiet, J.; Silvestri, C.; Baldassarre, L.; Ucciferri, C.; Orsetti, E.; Castelli, P.; Provinciali, M.; et al. Quorum sensing inhibitor FS3-coated vascular graft enhances daptomycin efficacy in a rat model of staphylococcal infection. Peptides 2013, 40, 77-81. [CrossRef] [PubMed].
30. Simonetti, O.; Cirioni, O.; Mocchegiani, F.; Cacciatore, I.; Silvestri, C.; Baldassarre, L.; Orlando, F.; Castelli, P.; Provinciali, M.; Vivarelli, M.; et al. The efficacy of the quorum sensing inhibitor FS8 and tigecycline in preventing prosthesis biofilm in an animal model of staphylococcal infection. Int. J. Mol. Sci. 2013, 14, 16321-16332. [CrossRef] [PubMed].
31. Thompson, J. A.; Oliveira, R. A.; Djukovic, A.; Ubeda, C.; Xavier, K. B. Manipulation of the quorum sensing signal AI-2 affects the antibiotic-treated gut microbiota. Cell Rep. 2015, 10, 1861-1871. [CrossRef] [PubMed].
32. Roy, V.; Smith, J. A. I.; Wang, J.; Stewart, J. E.; Bentley, W. E.; Sintim, H. O. Synthetic analogs tailor native AI-2 signaling across bacterial species. J. Am. Chem. Soc. 2010, 132, 11141-11150. [CrossRef] [PubMed].
33. Brackman, G.; Celen, S.; Hillaert, U.; van Calenbergh, S.; Cos, P.; Maes, L.; Nelis, H. J.; Coenye, T. Structure-activity relationship of cinnamaldehyde analogs as inhibitors of AI-2 based quorum sensing and their effect on virulence of Vibrio spp. PLoS ONE 2011, 6, e16084. [CrossRef] [PubMed].
34. Brackman, G.; Defoirdt, T.; Miyamoto, C.; Bossier, P.; Calenbergh, S. V.; Nelis, H.; Coenyie, T. Cinnamaldehyde and cinnamaldehyde derivatives reduce virulence in Vibrio spp. by decreasing the DNA-binding activity of the quorum sensing response regulator LuxR. BMC Microbiol. 2008, 8, 149-162. [CrossRef] [PubMed].
35. Lu, C.; Kirsch, B.; Zimmer, C.; de Jong, J. C.; Henn, C.; Maurer, C. K.; Müsken, M.; Häussler, S.; Steinbach, A.; Hartmann, R. W. Discovery of antagonists of PqsR, a key player in 2-alkyl-4-quinolone-dependent quorum sensing in Pseudomonas aeruginosa. Chem. Biol. 2012, 19, 381-390. [CrossRef] [PubMed].
36. Sahner, J. H.; Empting, M.; Kamal, A.; Weidel, E.; Groh, M.; Börger, C.; Hartmann, R. W. Exploring the chemical space of ureidothiophene-2-carboxylic acids as inhibitors of the quorum sensing enzyme PqsD from Pseudomonas aeruginosa. Eur. J. Med. Chem. 2015, 96, 14-21. [CrossRef] [PubMed].
37. Defoirdt, T.; Brackman, G.; Coenye, T. Quorum sensing inhibitors: How strong is the evidence? Trends Microbiol. 2013, 21, 619-624. [CrossRef] [PubMed].
38. De Carvalho, M. P.; Abraham, W.-R. Antimicrobial and biofilm inhibiting diketopiperazines. Curr. Med. Chem. 2012, 19, 3564-3577. [CrossRef] [PubMed].
39. Holden, M. T. G.; Chhabra, S. R.; de Nys, R.; Stead, P.; Bainton, N. J.; Hill, P. J.; Manefeld, M.; Kumar, N.; Labatte, M.; England, D.; et al. Quorum-sensing cross talk: Isolation and chemical characterization of cyclic dipeptides from Pseudomonas aeruginosa and other Gram-negative bacteria. Mol. Microbiol. 1999, 33, 1254-1266. [CrossRef] [PubMed].
40. Campbell, J.; Lin, Q.; Geske, G. D.; Blackwell, H. E. New and unexpected insights into the modulation of LuxR-type quorum sensing by cyclic dipeptides. ACS Chem. Biol. 2009, 4, 1051-1059. [CrossRef] [PubMed].
41. Ryan, R. P.; Dow, J. M. Diffusible signals and interspecies communication in bacteria. Microbiology 2008, 154, 1845-1858. [CrossRef] [PubMed].
42. Li, J.; Wang, W.; Xu, S. X.; Magarvey, N. A.; McCormick, J. K. Lactobacillus reuteri-produced cyclic dipeptides quench agr-mediated expression of toxic shock syndrome toxin-1 in staphylococci. Proc. Natl. Acad. Sci. USA 2011, 108, 3360-3365. [CrossRef] [PubMed].
43. Scopel, M.; Abraham, W.-R.; Henriques, A. T.; Macedo, A. J. Dipeptide cis-cyclo(leucyl-tyrosyl) produced by sponge associated Penicillium sp. F37 inhibits biofilm formation of the pathogenic Staphylococcus epidermidis. Bioorganic Med. Chem. Lett. 2013, 23, 624-626. [CrossRef] [PubMed].
44. Brackman, G.; Hillaert, U.; Calenbergh, S. V.; Nelis, H. J.; Coenye, T. Use of quorum sensing inhibitors to interfere with biofilm formation and development in Burkholderia multivorans and Burkholderia cenocepacia. Res. Microbiol. 2009, 160, 144-151. [CrossRef] [PubMed].
45. Song, J.; Choi, B.; Jin, E. J.; Yoon, Y.; Choi, K. H. Curcumin suppresses Streptococcus mutans adherence to human tooth surfaces and extracellular matrix proteins. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31, 1347-1352. [CrossRef] [PubMed].
46. Hu, P.; Huang, P.; Chen, M. W. Curcumin reduces Streptococcus mutans biofilm formation by inhibiting sortase A activity. Arch. Oral Biol. 2013, 58, 1343-1348. [CrossRef] [PubMed].
47. Arora, D. P.; Hossain, S.; Xu, Y.; Boon, E. M. Nitric oxide regulation of bacterial biofilms. Biochemistry 2015, 54, 3717-3728. [CrossRef] [PubMed].
48. Barraud, N.; Hassett, D. J.; Hwang, S. H.; Rice, S. A.; Kjelleberg, S.; Webb, J. S. Involvement of nitric oxide in biofilm dispersal of Pseudomonas aeruginosa. J. Bacteriol. 2006, 188, 7344-7353. [CrossRef] [PubMed].
49. Potter, A. J.; Kidd, S. P.; Edwards, J. L.; Falsetta, M. L.; Apicella, M. A.; Jennings, M. P.; McEwan, A. G. Thioredoxin reductase is essential for protection of Neisseria gonorrhoeae against killing by nitric oxide and for bacterial growth during interaction with cervical epithelial cells. J. Infect. Dis. 2009, 199, 227-235. [CrossRef] [PubMed].
50. Schlag, S.; Nerz, C.; Birkenstock, T. A.; Altenberend, F.; Götz, F. Inhibition of staphylococcal biofilm formation by nitrite. J. Bacteriol. 2007, 189, 7911-7919. [CrossRef] [PubMed].
51. Barraud, N.; Storey, M. V.; Moore, Z. P.; Webb, J. S.; Rice, S. A.; Kjelleberg, S. Nitric oxide-mediated dispersal in single-and multi-species biofilms of clinically and industrially relevant microorganisms. Microb. Biotechnol. 2009, 2, 370-378. [CrossRef] [PubMed].
52. Wilken, M.; Huchzermeyer, B. Suppression of mycelia formation by NO produced endogenously in Candida tropicalis. Eur. J. Cell Biol. 1999, 78, 209-213. [CrossRef].
53. Babaei, S.; Teichert-Kuliszewska, K.; Monge, J. C.; Mohamed, F.; Bendeck, M. P.; Stewart, D. J. Role of nitric oxide in the angiogenic response in vitro to basic fibroblast growth factor. Circ. Res. 1998, 82, 1007-1015. [CrossRef] [PubMed].
54. Ridnour, L. A.; Thomas, D. D.; Mancardi, D.; Espey, M. G.; Miranda, K. M.; Paolocci, N.; Feelisch, M.; Fukuto, J.; Wink, D. A. The chemistry of nitrosative stress induced by nitric oxide and reactive nitrogen oxide species. Putting perspective on stressful biological situations. Biol. Chem. 2004, 385, 1-10. [CrossRef] [PubMed].
55. Miller, C. Inhaled nitric oxide. In Proceedings of the 36th European Cystic Fibrosis Conference, Lisbon, Portugal, 12-15 June 2013; Available online: http://www. hopkinscme. net/ofp/eCysticFibrosisReview/newsletters/2013/0913. html (accessed on 5 January 2016).
56. Keefer, L. K. Fifty years of diazeniumdiolate research. From laboratory curiosity to broad-spectrum biomedical advances. ACS Chem. Biol. 2011, 6, 1147-1155. [CrossRef] [PubMed].
57. Barraud, N.; Kardak, B. G.; Yepuri, N. R.; Howlin, R. P.; Webb, J. S.; Faust, S. N.; Kjelleberg, S.; Rice, S. A.; Kelso, M. J. Cephalosporin-31-diazeniumdiolates: Targeted NO-donor prodrugs for dispersing bacterial biofilms. Angew. Chem. Int. Ed. 2012, 51, 9057-9060. [CrossRef] [PubMed].
58. Sun, B.; Slomberg, D. L.; Chudasama, S. L.; Lu, Y.; Schoenfisch, M. H. Nitric oxide-releasing dendrimers as antibacterial agents. Biomacromolecules 2012, 13, 3343-3354. [CrossRef] [PubMed].
59. Nablo, B. J.; Rothrock, A. R.; Schoenfisch, M. H. Nitric oxide-releasing sol-gels as antibacterial coatings for orthopedic implants. Biomaterials 2005, 26, 917-924. [CrossRef] [PubMed].
60. Barraud, N.; Kelso, M. J.; Rice, S. A.; Kjelleberg, S. Nitric oxide: A key mediator of biofilm dispersal with applications in infectious diseases. Curr. Pharm. Des. 2015, 21, 31-42. [CrossRef] [PubMed].
61. Davies, D. G.; Marques, C. N. H. A fatty acid messenger is responsible for inducing dispersion in microbial biofilms. J. Bacteriol. 2009, 191, 1393-1403. [CrossRef] [PubMed].
62. Ryan, R. P.; McCarthy, Y.; Watt, S. A.; Niehaus, K.; Dow, J. M. Intraspecies signaling involving the diffusible signal factor BDSF (cis-2-dodecenoic acid) influences virulence in Burkholderia cenocepacia. J. Bacteriol. 2009, 191, 5013-5019. [CrossRef] [PubMed].
63. Udine, C.; Brackman, G.; Bazzini, S.; Buroni, S.; van Acker, H.; Pasca, M. R.; Riccardi, G.; Coenye, T. Phenotypic and genotypic characterisation of Burkholderia cenocepacia J2315 mutants affected in homoserine lactone and diffusible signal factor-based quorum sensing systems suggests interplay between both types of systems. PLoS ONE 2013, 8, e55112. [CrossRef] [PubMed].
64. Rahmani-Badi, A.; Sepehr, S.; Fallahi, H.; Heidari-Keshel, S. Dissection of the cis-2-decenoic acid signaling network in Pseudomonas aeruginosa using microarray technique. Front. Microbiol. 2015, 6. [CrossRef] [PubMed].
65. Huang, T. P.; Wong, A. C. Extracellular fatty acids facilitate flagella-independent translocation by Stenotrophomonas maltophilia. Res. Microbiol. 2007, 158, 702-711. [CrossRef] [PubMed].
66. Ryan, R. P.; Fouhy, Y.; Garcia, B. F.; Watt, S. A.; Niehaus, K.; Yang, L.; Tolker-Nielsen, T.; Dow, J. M. Interspecies signalling via the Stenotrophomonas maltophilia diffusible signal factor influences biofilm formation and polymyxin tolerance in Pseudomonas aeruginosa. Mol. Microbiol. 2008, 68, 75-86. [CrossRef] [PubMed].
67. Inoue, T.; Shingaki, R.; Fukui, K. Inhibition of swarming motility of Pseudomonas aeruginosa by branched-chain fatty acids. FEMS Microbiol. Lett. 2008, 281, 81-86. [CrossRef] [PubMed].
68. Boon, C.; Deng, Y.; Wang, L.-H.; He, Y.; Xu, J.-L.; Fan, Y.; Pan, S. Q.; Zhang, L.-H. A novel DSF-like signal from Burkholderia cenocepacia interferes with Candida albicans morphological transition. ISME J. 2008, 2, 27-36. [CrossRef] [PubMed].
69. Deng, Y.; Boon, C.; Chen, S.; Lim, A.; Zhang, L.-H. Cis-2-dodecenoic acid signal modulates virulence of Pseudomonas aeruginosa through interference with quorum sensing systems and T3SS. BMC Microbiol. 2013, 13. [CrossRef] [PubMed].
70. Amari, D. T.; Marques, C. N. H.; Davies, D. G. The putative enoyl-coenzyme A hydratase DspI is required for production of the Pseudomonas aeruginosa biofilm dispersion autoinducer cis-2-decenoic acid. J. Bacteriol. 2013, 195, 4600-4610. [CrossRef] [PubMed].
71. Bi, H.; Christensen, Q. H.; Feng, Y.; Wang, H.; Cronan, J. E. The Burkholderia cenocepacia BDSF quorum sensing fatty acid is synthesized by a bifunctional crotonase homologue having both dehydratase and thioesterase activities. Mol. Microbiol. 2012, 83, 840-855. [CrossRef] [PubMed].
72. Ryan, R. P.; Dow, J. M. Communication with a growing family: Diffusible signal factor (DSF) signaling in bacteria. Trends Microbiol. 2011, 19, 145-152. [CrossRef] [PubMed].
73. Deng, Y.; Schmid, N.; Wang, C.; Wang, J.; Pessi, G.; Wu, D.; Lee, J.; Aguilar, C.; Ahrens, C. H.; Chang, C.; et al. Cis-2-dodecenoic acid receptor RpfR links quorum-sensing signal perception with regulation of virulence through cyclic dimeric guanosinemonophosphate turnover. Proc. Natl. Acad. Sci. USA. 2012, 109, 15479-15484. [CrossRef] [PubMed].
74. Huedo, P.; Yero, D.; Martínez-Servat, S.; Estibariz, I.; Planell, R.; Martínez, P.; Ruyra, A.; Roher, N.; Roca, I.; Vila, J.; et al. Two different rpf clusters distributed among a population of Stenotrophomonas maltophilia clinical strains display differential diffusible signal factor production and virulence regulation. J. Bacteriol. 2014, 196, 2431-2442. [CrossRef] [PubMed].
75. Marques, C. N. H.; Morozov, A.; Planzos, P.; Zelaya, H. M. The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state. Appl. Environ. Microbiol. 2014, 80, 6976-6991. [CrossRef] [PubMed].
76. Gutierrez, M.; Choi, M. H.; Tian, B.; Xu, J.; Rho, J. K.; Kim, M. O.; Cho, Y.-H.; Yoon, S. C. Simultaneous inhibition of rhamnolipid and polyhydroxyalkanoic acid synthesis and biofilm formation in Pseudomonas aeruginosa by 2-bromoalkanoic acids: Effect of inhibitor alkyl-chain-length. PLoS ONE 2013, 8, e73986. [CrossRef] [PubMed].
77. Su, Z.; Peng, L.; Worthington, R. J.; Melander, C. Evaluation of 4, 5-disubstituted-2-aminoimidazole-triazole conjugates for antibiofilm/antibiotic resensitization activity against MRSA and Acinetobacter baumannii. ChemMedChem 2011, 6, 2243-2251. [CrossRef] [PubMed].
78. Ren, D.; Zuo, R.; Barrios, A. F. G.; Bedzyk, L. A.; Eldridge, G. R.; Pasmore, M. E.; Wood, T. K. Differential gene expression for investigation of Escherichia coli biofilm inhibition by plant extract ursolic acid. Appl. Environ. Microbiol. 2005, 71, 4022-4034. [CrossRef] [PubMed].
79. Qin, N.; Tan, X.; Jiao, Y.; Liu, L.; Zhao, W.; Yang, S.; Jia, A. RNA-Seq-based transcriptome analysis of methicillin-resistant Staphylococcus aureus biofilm inhibition by ursolic acid and resveratrol. Sci. Rep. 2014, 4, 5467. [CrossRef] [PubMed].
80. Garo, E.; Eldridge, G. R.; Goering, M. G.; Pulcini, E. D.; Hamilton, M. A.; Costerton, J. W.; James, G. A. Asiatic acid and corosolic acid enhance the susceptibility of Pseudomonas aeruginosa biofilms to tobramycin. Antimicrob. Agents Chemother. 2007, 51, 1813-1817. [CrossRef] [PubMed].
81. Potterat, O.; Hostettmann, K.; Höltzel, A.; Jung, G.; Diehl, P. A.; Petrini, O. Boophiline, an antimicrobial sterol amide from the cattle tick Boophilus microplus. Helv. Chim. Acta 1997, 80, 2066-2072. [CrossRef].
82. Zimmer, K. R.; Macedo, A. J.; Giordani, R. B.; Conceição, J. M.; Nicastro, G. G.; Boechat, A. L.; Baldini, R. L.; Abraham, W.-R.; Termignoni, C. A steroidal molecule present in the egg wax of the tick Rhipicephalus (Boophilus) microplus inhibits bacterial biofilms. Environ. Microbiol. 2013, 15, 2008-2018. [CrossRef] [PubMed].
83. Forenza, S.; Minale, L.; Riccio, R.; Fattorusso, E. New bromo-pyrrole derivatives from the sponge Agelas oroides. J. Chem. Soc. D 1971, 18, 1129-1130. [CrossRef].
84. Kelly, S. R.; Jensen, P. R.; Henkel, T. P.; Fenical, W.; Pawlik, J. R. Effects of Caribbean sponge extracts on bacterial attachment. Aquat. Microb. Ecol. 2003, 31, 175-182. [CrossRef].
85. Žula, A.; Kikelj, D.; Ilaš, J. 2-Aminoimidazoles inmedicinal chemistry. Mini Rev. Med. Chem. 2013, 13, 1921-1943. [CrossRef] [PubMed].
86. Richards, J. J.; Reyes, S.; Stowe, S. D.; Tucker, A. T.; Ballard, T. E.; Mathies, L. D.; Cavanagh, J.; Melander, C. Amide isosteres of oroidin: Assessment of antibiofilm activity and C. elegans toxicity. J. Med. Chem. 2009, 52, 4582-4585. [CrossRef] [PubMed].
87. Ballard, T. E.; Richards, J. J.; Aquino, A.; Reed, C. S.; Melander, C. Antibiofilm activity of a diverse oroidin library generated through reductive acylation. J. Org. Chem. 2009, 74, 1755-1758. [CrossRef] [PubMed].
88. Hodnik, Ž.; Łós, J. M.; Žula, A.; Zidar, N.; Jakopin, Ž.; Łós, M.; Dolenc, M. S.; Ilaš, J.; Węgrzyn, G.; Mašič, L. P.; et al. Inhibition of biofilm formation by conformationally constrained indole-based analogues of the marine alkaloid oroidin. Bioorganic Med. Chem. Lett. 2014, 24, 2530-2534. [CrossRef] [PubMed].
89. Wright, C. J.; Wu, H.; Melander, R. J.; Melander, C.; Lamont, R. J. Disruption of heterotypic community development by Porphyromonas gingivalis with small molecule inhibitors. Mol. Oral Microbiol. 2014, 29, 185-193. [CrossRef] [PubMed].
90. Polo, A.; Foladori, P.; Ponti, B.; Bettinetti, R.; Gambino, M.; Villa, F.; Cappitelli, F. Evaluation of zosteric acid for mitigating biofilm formation of Pseudomonas putida isolated from a membrane bioreactor system. Int. J. Mol. Sci. 2014, 15, 9497-9518. [CrossRef] [PubMed].
91. Villa, F.; Pitts, B.; Stewart, P. S.; Giussani, B.; Roncoroni, S.; Albanese, D.; Giordano, C.; Tunesi, M.; Cappitelli, F. Efficacy of zosteric acid sodium salt on the yeast biofilm model Candida albicans. Microb. Ecol. 2011, 62, 584-598. [CrossRef] [PubMed].
92. Villa, F.; Remelli, W.; Forlani, F.; Vitali, A.; Cappitelli, F. Altered expression level of Escherichia coli proteins in response to treatment with the antifouling agent zosteric acid sodium salt. Environ. Microbiol. 2012, 14, 1753-1761. [CrossRef] [PubMed].
93. Cattò, C.; Dell'Orto, S.; Villa, F.; Villa, S.; Gelain, A.; Vitali, A.; Marzano, V.; Baroni, S.; Forlani, F.; Cappitelli, F. Unravelling the structural and molecular basis responsible for the anti-biofilm activity of zosteric acid. PLoS ONE 2015, 10, e0131519. [CrossRef] [PubMed].
94. Li, W.; Estrada-de los Santos, P.; Matthijs, S.; Xie, G. L.; Busson, R.; Cornelis, P.; Rozenski, J.; de Mot, R. Promysalin, a salicylate-containing Pseudomonas putida antibiotic, promotes surface colonization and selectively targets other Pseudomonas. Chem. Biol. 2011, 18, 1320-1330. [CrossRef] [PubMed].
95. Steele, A. D.; Knouse, K. W.; Keohane, C. E.; Wuest, W. M. Total synthesis and biological investigation of (α)-promysalin. J. Am. Chem. Soc. 2015, 137, 7314-7317. [CrossRef] [PubMed].
96. Clatworthy, A. E.; Pierson, E.; Hung, D. T. Targeting virulence: A new paradigm for antimicrobial therapy. Nat. Chem. Biol. 2007, 3, 541-548. [CrossRef] [PubMed].
97. Romilly, C.; Lays, C.; Tomasini, A.; Caldelari, I.; Benito, Y.; Hammann, P.; Geissmann, T.; Boisset, S.; Romby, P.; Vandenesch, F. A non-coding RNA promotes bacterial persistence and decreases virulence by regulating a regulator in Staphylococcus aureus. PLoS Pathog. 2014, 10, e1003979. [CrossRef] [PubMed].
98. Rasmussen, T. B.; Skindersoe, M. E.; Bjarnsholt, T.; Phipps, R. K.; Christensen, K. B.; Jensen, P. O.; Andersen, J. B.; Koch, B.; Larsen, T. O.; Hentzer, M.; et al. Identity and effects of quorum-sensing inhibitors produced by Penicillium. species. Microbiology 2005, 151, 1325-1340. [CrossRef] [PubMed].
99. Sepehr, S.; Rahmani-Badi, A.; Babaie-Naiej, H.; Soudi, M. R. Unsaturated fatty acid, cis-2-decenoic acid, in combination with disinfectants or antibiotics removes pre-established biofilms formed by food-related bacteria. PLoS ONE 2014, 9, e101677. [CrossRef] [PubMed].
100. Deng, Y.; Lim, A.; Lee, J.; Chen, S.; An, S.; Dong, Y.-H.; Zhang, L.-H. Diffusible signal factor (DSF) quorum sensing signal and structurally related molecules enhance the antimicrobial efficacy of antibiotics against some bacterial pathogens. BMC Microbiol. 2014, 14. [CrossRef] [PubMed].
101. Rahmani-Badi, A.; Sepehr, S.; Mohammadi, P.; Soudi, M. R.; Babaie-Naiej, H.; Fallahi, H. A combination of cis-2-decenoic acid and antibiotics eradicates pre-established catheter-associated biofilms. J. Med. Microbiol. 2014, 63, 1509-1516.
102. García-Contreras, R.; Maeda, T.; Wood, T. K. Can resistance against quorum-sensing interference be selected? ISME J. 2015, 10, 4-10. [CrossRef] [PubMed].
103. Johns, B. E.; Purdy, K. J.; Tucker, N. P.; Maddocks, S. E. Phenotypic and genotypic characteristics of small colony variants and their role in chronic infection. Microbiol. Insights 2015, 8, 15-23. [PubMed].
104. García-Contreras, R.; Peréz-Eretza, B.; Jasso-Chávez, R.; Lira-Silva, E.; Roldán-Sánchez, J. A.; González-Valdez, A.; Soberón-Chávez, G.; Coria-Jiménez, R.; Martínez-Vázquez, M.; Alcaraz, L. D.; et al. High variability in quorum quenching and growth inhibition by furanone C-30 in Pseudomonas aeruginosa clinical isolates from cystic fibrosis patients. Pathog. Dis. 2015, 73, ftv040. [CrossRef] [PubMed].
105. Grandclément, C.; Tannières, M.; Moréra, S.; Dessaux, Y.; Faure, D. D. Quorum quenching: Role in nature and applied developments. FEMS Microbiol. Rev. 2015. [CrossRef] [PubMed].
106. Gopal, R.; Lee, J. H.; Kim, Y. G.; Kim, M. S.; Seo, C. H.; Park, Y. Anti-microbial, anti-biofilm activities and cell selectivity of the NRC-16 peptide derived from witch flounder, Glyptocephalus cynoglossus. Mar. Drugs 2013, 11, 1836-1852. [CrossRef] [PubMed].
107. Jiang, F.; Deng, Y.; Yeh, C. K.; Sun, Y. Quaternized chitosans bind onto preexisting biofilms and eradicate pre-attached microorganisms. J. Mater. Chem. B Mater. Biol. Med. 2014, 2, 8518-8527. [CrossRef] [PubMed].
108. Zupancic, S.; Kocbek, P.; Baumgartner, S.; Kristl, J. Contribution of nanotechnology to improved treatment of periodontal disease. Curr. Pharm. Des. 2015, 21, 3257-3271. [CrossRef] [PubMed].
109. Rawson, M.; Haggard, W.; Jennings, J. A. Osteocompatibility of biofilm inhibitors. Open Orthop. J. 2014, 8, 442-449. [PubMed].